China Kanghui Holdings Reports Q4 EPS of $0.17 vs. $0.17

China Kanghui Holdings

(“Kanghui” or the “Company”), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced financial results for the fourth quarter and full year of 2010. Net revenue increased 33.1% to RMB72.3 million ($11.0 million1) from RMB54.3 million in the same period of the prior year; Net income increased 63.7% to RMB27.5 million ($4.2 million) from RMB16.8 million in the same period of the prior year. This is equivalent to approximately RMB1.10 ($0.17) per diluted ADS2 in the fourth quarter of 2010; Non-GAAP net income, which excludes share based compensation expense, increased 45.4% to RMB28.2 million ($4.3 million) from RMB19.4 million in the same period of the prior year. This is equivalent to approximately RMB1.12 ($0.17) per diluted ADS in the fourth quarter of 2010.